Show simple item record

The necessity, efficacy and safety of biologics in juvenile idiopathic arthritis

dc.contributor.authorKaradag, SG
dc.contributor.authorAyaz, Nuray
dc.contributor.authorTanatar, Ayşe
dc.contributor.authorCakan, M
dc.date.accessioned2021-03-05T07:49:34Z
dc.date.available2021-03-05T07:49:34Z
dc.date.issued2020
dc.identifier.citationCakan M., Ayaz N., Karadag S., Tanatar A., "The necessity, efficacy and safety of biologics in juvenile idiopathic arthritis", NORTHERN CLINICS OF ISTANBUL, cilt.7, ss.118-123, 2020
dc.identifier.othervv_1032021
dc.identifier.otherav_95c2b475-ebf7-4381-a214-5e4086e01ef6
dc.identifier.urihttp://hdl.handle.net/20.500.12627/100845
dc.identifier.urihttps://doi.org/10.14744/nci.2019.57873
dc.description.abstractOBJECTIVE: Juvenile idiopathic arthritis (JIA) is the most common cause of chronic arthritis in children. Biologics have changed the faith of children with rheumatic diseases. The main objective of this study was to demonstrate the rate of usage, efficacy and safety of biologics in JIA subtypes.
dc.language.isoeng
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectTIP, GENEL & İÇECEK
dc.titleThe necessity, efficacy and safety of biologics in juvenile idiopathic arthritis
dc.typeMakale
dc.relation.journalNORTHERN CLINICS OF ISTANBUL
dc.contributor.department, ,
dc.identifier.volume7
dc.identifier.issue2
dc.identifier.startpage118
dc.identifier.endpage123
dc.contributor.firstauthorID837921


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record